Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Helix BioPharma Corp appoints new independent Chair of Board


Monday, 21 Jul 2014 09:15am EDT 

Helix BioPharma Corp:Appoints Yvon Bastien as new Chair of the board effective July 17.Bastien has served as an independent director of the Company since Dec. 2013 and remains Chair of the board's Governance & Compensation Committee.Robert Verhagen has served as Interim Chair since Dec. 2013 and remains Director of the Company and President and CEO. 

Company Quote

1.6
0.04 +2.56%
17 Dec 2014